Sotorasib covalently binds to the switch pocket of KRAS G12C mutant protein, specifically inhibits GTPase activity and blocks abnormal RAS signaling.
Authentic
Guarantee
Fast Delivery
Privacy Against the backdrop of increasing challenges in access to innovative drugs, the Laos Dabear version of Sotorasib, with its active ingredients highly ···【More】
Update: 03 Jun,2026Source: BigbearViews: 156
In recent years, the quietly emerged Lao Big Bear version of Sotorasib, an affordable alternative to this targeted therapy for refractory KRAS G12C mu···【More】
Update: 03 Jun,2026Source: BigbearViews: 176
The Laotian Bear version of Sotorasib, as the first generic version of the world's first approved KRAS G12C inhibitor original drug, is produced b···【More】
Update: 03 Jun,2026Source: BigbearViews: 142
Sotorasib (also known as LUMAKRAS) is an innovative targeted therapy for KRASG12C-mutant non-small cell lung cancer (NSCLC). Due to its unique pharmac···【More】
Update: 12 Mar,2026Source: BigbearViews: 164
Publicly available information shows that the price of the original brand-name drug Sotorasib is generally between $1,300 and $2,500, with the exact p···【More】
Update: 12 Mar,2026Source: BigbearViews: 182
Sotorasib is a targeted therapy for KRAS G12C-mutant non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, dosage, p···【More】
Update: 25 Feb,2026Source: BigbearViews: 161
Sotorasib (generic name: Sotorasib) is a prescription drug targeting a specific gene mutation (KRAS G12C) in non-small cell lung cancer. Its price is ···【More】
Update: 25 Feb,2026Source: BigbearViews: 162
The price of Sotorasib varies significantly depending on the region, purchase channel, and dosage. The specific price should be confirmed with the hos···【More】
Update: 25 Feb,2026Source: BigbearViews: 156
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos